Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jim Thom

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|May 29, 2004
Evaluation of the phospholipid-rich dilute Russell's viper venom assay to monitor oral anticoagulation in patients with lupus anticoagulantJim Thom, Leesa Ivey, Grace Gilmore, et al.
Haematologica|September 2, 2004
Anti-tissue factor pathway inhibitor activity in subjects with antiphospholipid syndrome is associated with increased thrombin generationMurray Adams, Liza Breckler, Paul Stevens, et al.
Seminars in Thrombosis and Hemostasis|April 12, 2007
Emerging technologies in hemostasis diagnostics: a report from the Australasian Society of Thrombosis and Haemostasis Emerging Technologies GroupMurray Adams, Chris Ward, Jim Thom, et al.
International Journal of Laboratory Hematology|April 4, 2008
A rapid flow cytometric technique for the detection of platelet-monocyte complexes, activated platelets and platelet-derived microparticlesLaura Pearson, Jim Thom, Murray Adams, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 1, 2007
Polymorphisms of the tissue factor pathway inhibitor gene are associated with venous thromboembolism in the antiphospholipid syndrome and carriers of factor V LeidenLisa F Lincz, Murray J Adams, Fiona E Scorgie, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 22, 2006
The tissue factor pathway in ischemic strokeMurray J Adams, Jim Thom, Graeme J Hankey, et al.
Haematologica|October 5, 2006
The effects of tissue factor pathway inhibitor and anti-beta-2-glycoprotein-I IgG on thrombin generationSim Yee Lean, Paul Ellery, Leesa Ivey, et al.
Thrombosis Research|December 10, 2008
Desmopressin therapy to assist the functional identification and characterisation of von Willebrand disease: differential utility from combining two (VWF:CB and VWF:RCo) von Willebrand factor activity assays?Emmanuel J Favaloro, Jim Thom, David Patterson, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|October 2, 2007
C-reactive protein in ischemic stroke and its etiologic subtypesJohn W Eikelboom, Graeme J Hankey, Ross I Baker, et al.
Stroke|August 9, 2003
Endothelial and platelet activation in acute ischemic stroke and its etiological subtypesPaul Cherian, Graeme J Hankey, John W Eikelboom, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|May 29, 2004
Evaluation of the phospholipid-rich dilute Russell's viper venom assay to monitor oral anticoagulation in patients with lupus anticoagulantJim Thom, Leesa Ivey, Grace Gilmore, et al.
Haematologica|September 2, 2004
Anti-tissue factor pathway inhibitor activity in subjects with antiphospholipid syndrome is associated with increased thrombin generationMurray Adams, Liza Breckler, Paul Stevens, et al.
Seminars in Thrombosis and Hemostasis|April 12, 2007
Emerging technologies in hemostasis diagnostics: a report from the Australasian Society of Thrombosis and Haemostasis Emerging Technologies GroupMurray Adams, Chris Ward, Jim Thom, et al.
International Journal of Laboratory Hematology|April 4, 2008
A rapid flow cytometric technique for the detection of platelet-monocyte complexes, activated platelets and platelet-derived microparticlesLaura Pearson, Jim Thom, Murray Adams, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 1, 2007
Polymorphisms of the tissue factor pathway inhibitor gene are associated with venous thromboembolism in the antiphospholipid syndrome and carriers of factor V LeidenLisa F Lincz, Murray J Adams, Fiona E Scorgie, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 22, 2006
The tissue factor pathway in ischemic strokeMurray J Adams, Jim Thom, Graeme J Hankey, et al.
Haematologica|October 5, 2006
The effects of tissue factor pathway inhibitor and anti-beta-2-glycoprotein-I IgG on thrombin generationSim Yee Lean, Paul Ellery, Leesa Ivey, et al.
Thrombosis Research|December 10, 2008
Desmopressin therapy to assist the functional identification and characterisation of von Willebrand disease: differential utility from combining two (VWF:CB and VWF:RCo) von Willebrand factor activity assays?Emmanuel J Favaloro, Jim Thom, David Patterson, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|October 2, 2007
C-reactive protein in ischemic stroke and its etiologic subtypesJohn W Eikelboom, Graeme J Hankey, Ross I Baker, et al.
Stroke|August 9, 2003
Endothelial and platelet activation in acute ischemic stroke and its etiological subtypesPaul Cherian, Graeme J Hankey, John W Eikelboom, et al.
Pageof 2